Animal-free alternatives and the antibody iceberg

Affiliations

¹ Afability, Nottingham, UK. draligray@afability.com.
² School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK. draligray@afability.com.
³ Specifica, Santa Fe, NM, USA.
⁴ Bio-Rad, Puchheim, Germany.
⁵ University of Zurich, Zurich, Switzerland.
⁶ University of Lund, Lund, Sweden.
⁷ Technische Universität Braunschweig, Braunschweig, Germany.

Alison Gray et al. Nat Biotechnol. 2020 Nov.

. 2020 Nov;38(11):1234-1239.

doi: 10.1038/s41587-020-0687-9.

¹ Afability, Nottingham, UK. draligray@afability.com.
² School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK. draligray@afability.com.
³ Specifica, Santa Fe, NM, USA.
⁴ Bio-Rad, Puchheim, Germany.
⁵ University of Zurich, Zurich, Switzerland.
⁶ University of Lund, Lund, Sweden.
⁷ Technische Universität Braunschweig, Braunschweig, Germany.

No abstract available

References

1. Gray, A. C., Sidhu, S. S., Chandrasekera, P. C., Hendriksen, C. F. M. & Borrebaeck, C. A. K. Trends Biotechnol. 34, 960–969 (2016). - DOI - PubMed - PMC
1. Gray, A. C., Sidhu, S. S., Chandrasekera, P. C., Hendriksen, C. F. M. & Borrebaeck, C. A. K. Science 353, 452–453 (2016). - DOI
1. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. http://data.europa.eu/eli/dir/2010/63/oj (2010).
1. Barroso, J., Halder, M. & Whelan, M. EURL ECVAM recommendation on non-animal-derived antibodies. EUR 30185 EN (European Union, 2020); https://doi.org/10.2760/091625
1. Bradbury, A. R. M. et al. MAbs 10, 539–546 (2018). - DOI - PubMed - PMC